Skip to main content
NCBI home page
British Heart Journal logoLink to British Heart Journal
. 1986 Jul;56(1):27–32. doi: 10.1136/hrt.56.1.27

Incidence of spasm at the site of previous successful transluminal coronary angioplasty: effect of ergometrine maleate in consecutive patients.

A A Quyyumi, M Raphael, E J Perrins, L M Shapiro, A F Rickards, K M Fox
PMCID: PMC1277382  PMID: 2942159

Abstract

The incidence of coronary artery spasm at the site of previous successful angioplasty and its importance in leading to subsequent restenosis or recurrence of symptoms are unknown. Fourteen consecutive patients with single vessel coronary artery disease who had undergone successful percutaneous transluminal angioplasty were studied. All patients were given ergometrine maleate (ergonovine maleate) intravenously during repeat cardiac catheterisation six weeks to three months after angioplasty. Five patients demonstrated excessive luminal reduction (spasm) at the site of previous angioplasty that led to luminal stenoses ranging from 50% to 79%. Two of these patients developed chest pain and ST segment changes during ergometrine maleate provocation and they also showed maximal vasoconstriction. The remaining nine patients did not develop important luminal change at the site of angioplasty after ergometrine maleate. Ergometrine maleate administration resulted in less than or equal to 20% reduction in lumen diameter of adjacent apparently normal sections of the coronary arteries in all but two patients. At the site of previous angioplasty in the five patients with spasm, however, the lumen was constricted by a mean (SD) of 51 (12)%, whereas in the nine patients not demonstrating spasm mean reduction was 12 (7)%. Thus hypersensitivity to ergometrine maleate at the site of previous successful angioplasty was demonstrated in over a third of consecutive patients with single vessel coronary artery disease. The importance of this finding to long term results of coronary angioplasty needs to be investigated further.

Full text

PDF
27

Images in this article

30Fig. 4
on p.30

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baughman K. L., Pasternak R. C., Fallon J. T., Block P. C. Transluminal coronary angioplasty of postmortem human hearts. Am J Cardiol. 1981 Dec;48(6):1044–1047. doi: 10.1016/0002-9149(81)90318-0. [DOI] [PubMed] [Google Scholar]
  2. Block P. C., Myler R. K., Stertzer S., Fallon J. T. Morphology after transluminal angioplasty in human beings. N Engl J Med. 1981 Aug 13;305(7):382–385. doi: 10.1056/NEJM198108133050706. [DOI] [PubMed] [Google Scholar]
  3. Brown B. G. Coronary vasospasm. Observations linking the clinical spectrum of ischemic heart disease to the dynamic pathology of coronary atherosclerosis. Arch Intern Med. 1981 May;141(6):716–722. doi: 10.1001/archinte.141.6.716. [DOI] [PubMed] [Google Scholar]
  4. Curry R. C., Jr, Pepine C. J., Sabom M. B., Feldman R. L., Christie L. G., Conti C. R. Effects of ergonovine in patients with and without coronary artery disease. Circulation. 1977 Nov;56(5):803–809. doi: 10.1161/01.cir.56.5.803. [DOI] [PubMed] [Google Scholar]
  5. David P. R., Waters D. D., Scholl J. M., Crépeau J., Szlachcic J., Lespérance J., Hudon G., Bourassa M. G. Percutaneous transluminal coronary angioplasty in patients with variant angina. Circulation. 1982 Oct;66(4):695–702. doi: 10.1161/01.cir.66.4.695. [DOI] [PubMed] [Google Scholar]
  6. Essed C. E., Van den Brand M., Becker A. E. Transluminal coronary angioplasty and early restenosis. Fibrocellular occlusion after wall laceration. Br Heart J. 1983 Apr;49(4):393–396. doi: 10.1136/hrt.49.4.393. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Freedman B., Richmond D. R., Kelly D. T. Pathophysiology of coronary artery spasm. Circulation. 1982 Oct;66(4):705–709. doi: 10.1161/01.cir.66.4.705. [DOI] [PubMed] [Google Scholar]
  8. Grüntzig A. R., Senning A., Siegenthaler W. E. Nonoperative dilatation of coronary-artery stenosis: percutaneous transluminal coronary angioplasty. N Engl J Med. 1979 Jul 12;301(2):61–68. doi: 10.1056/NEJM197907123010201. [DOI] [PubMed] [Google Scholar]
  9. Hellstrom H. R. Evidence in favor of the vasospastic cause of coronary artery thrombosis. Am Heart J. 1979 Apr;97(4):449–452. doi: 10.1016/0002-8703(79)90391-0. [DOI] [PubMed] [Google Scholar]
  10. Heupler F. A., Jr, Proudfit W. L., Razavi M., Shirey E. K., Greenstreet R., Sheldon W. C. Ergonovine maleate provocative test for coronary arterial spasm. Am J Cardiol. 1978 Apr;41(4):631–640. doi: 10.1016/0002-9149(78)90810-x. [DOI] [PubMed] [Google Scholar]
  11. Hollman J., Austin G. E., Gruentzig A. R., Douglas J. S., Jr, King S. B., 3rd Coronary artery spasm at the site of angioplasty in the first 2 months after successful percutaneous transluminal coronary angioplasty. J Am Coll Cardiol. 1983 Dec;2(6):1039–1045. doi: 10.1016/s0735-1097(83)80327-1. [DOI] [PubMed] [Google Scholar]
  12. Salerno D. M., Granrud G., Sharkey P., Asinger R., Hodges M. A controlled trial of propafenone for treatment of frequent and repetitive ventricular premature complexes. Am J Cardiol. 1984 Jan 1;53(1):77–83. doi: 10.1016/0002-9149(84)90687-8. [DOI] [PubMed] [Google Scholar]
  13. Schroeder J. S., Bolen J. L., Quint R. A., Clark D. A., Hayden W. G., Higgins C. B., Wexler L. Provocation of coronary spasm with ergonovine maleate. New test with results in 57 patients undergoing coronary arteriography. Am J Cardiol. 1977 Oct;40(4):487–491. doi: 10.1016/0002-9149(77)90060-1. [DOI] [PubMed] [Google Scholar]
  14. Waller B. F., McManus B. M., Gorfinkel H. J., Kishel J. C., Schmidt E. C., Kent K. M., Roberts W. C. Status of the major epicardial coronary arteries 80 to 150 days after percutaneous transluminal coronary angioplasty. Analysis of 3 necropsy patients. Am J Cardiol. 1983 Jan 1;51(1):81–84. doi: 10.1016/s0002-9149(83)80015-0. [DOI] [PubMed] [Google Scholar]

Articles from British Heart Journal are provided here courtesy of BMJ Publishing Group

RESOURCES